Early IL-6 Levels Predict Sepsis-Induced Coagulopathy with High Specificity

Sepsis remains a primary driver of critical illness and mortality in the United States, characterized by a dysregulated host response to infection that frequently leads to multi-organ failure [1]. A central feature of this pathology is the systemic activation of inflammatory and coagulation pathways, often manifesting as sepsis-induced coagulopathy, a precursor to the more lethal disseminated intravascular coagulation [2]. While early goal-directed resuscitation and prompt antibiotic administration remain the cornerstones of management, identifying which patients will progress to severe hematologic dysfunction remains a significant clinical challenge [3]. Interleukin-6 has long been recognized as a key mediator in this inflammatory cascade, serving as a biomarker for both neonatal sepsis and the cytokine storms observed in severe viral infections [4, 5]. A new study investigates whether specific thresholds of this cytokine can predict the onset of overt coagulopathy before standard clinical scores manifest.